BACKGROUND: Angptl4 is a secreted protein involved in the regulation of vascular permeability, angiogenesis, and inflammatory responses in different kinds of tissues. Increases of vascular permeability and abnormality changes in angiogenesis contribute to the pathogenesis of tumor metastasis, ischemic-reperfusion injury. Inflammatory response associated with Angptl4 also leads to minimal change glomerulonephritis, wound healing. However, the role of Angptl4 in vascular permeability, angiogenesis, and inflammation is controversy. Hence, an underlying mechanism of Angptl4 in different kind of tissues needs to be further clarified. METHODS: Keywords such as angptl4, vascular permeability, angiogenesis, inflammation, and endothelial cells were used in search tool of PUBMED, and then the literatures associated with Angptl4 were founded and read. RESULTS: Data have established Angptl4 as the key modulator of both vascular permeability and angiogenesis; furthermore, it may also be related to the progression of metastatic tumors, cardiovascular events, and inflammatory diseases. This view focuses on the recent advances in our understanding of the role of Angptl4 in vascular permeability, angiogenesis, inflammatory signaling and the link between Angptl4 and multiple diseases such as cancer, cardiovascular diseases, diabetic retinopathy, and kidney diseases. CONCLUSIONS: Taken together, Angptl4 modulates vascular permeability, angiogenesis, inflammatory signaling, and associated diseases. The use of Angptl4-modulating agents such as certain drugs, food constituents (such as fatty acids), nuclear factor (such as PPARα), and bacteria may treat associated diseases such as tumor metastasis, ischemic-reperfusion injury, inflammation, and chronic low-grade inflammation. However, the diverse physiological functions of Angptl4 in different tissues can lead to potentially deleterious side effects when used as a therapeutic target. In this regard, a better understanding of the underlying mechanisms for Angptl4 in different tissues is necessary.
BACKGROUND:Angptl4 is a secreted protein involved in the regulation of vascular permeability, angiogenesis, and inflammatory responses in different kinds of tissues. Increases of vascular permeability and abnormality changes in angiogenesis contribute to the pathogenesis of tumor metastasis, ischemic-reperfusion injury. Inflammatory response associated with Angptl4 also leads to minimal change glomerulonephritis, wound healing. However, the role of Angptl4 in vascular permeability, angiogenesis, and inflammation is controversy. Hence, an underlying mechanism of Angptl4 in different kind of tissues needs to be further clarified. METHODS: Keywords such as angptl4, vascular permeability, angiogenesis, inflammation, and endothelial cells were used in search tool of PUBMED, and then the literatures associated with Angptl4 were founded and read. RESULTS: Data have established Angptl4 as the key modulator of both vascular permeability and angiogenesis; furthermore, it may also be related to the progression of metastatic tumors, cardiovascular events, and inflammatory diseases. This view focuses on the recent advances in our understanding of the role of Angptl4 in vascular permeability, angiogenesis, inflammatory signaling and the link between Angptl4 and multiple diseases such as cancer, cardiovascular diseases, diabetic retinopathy, and kidney diseases. CONCLUSIONS: Taken together, Angptl4 modulates vascular permeability, angiogenesis, inflammatory signaling, and associated diseases. The use of Angptl4-modulating agents such as certain drugs, food constituents (such as fatty acids), nuclear factor (such as PPARα), and bacteria may treat associated diseases such as tumor metastasis, ischemic-reperfusion injury, inflammation, and chronic low-grade inflammation. However, the diverse physiological functions of Angptl4 in different tissues can lead to potentially deleterious side effects when used as a therapeutic target. In this regard, a better understanding of the underlying mechanisms for Angptl4 in different tissues is necessary.
Authors: Royston-Luke Huang; Ziqiang Teo; Han Chung Chong; Pengcheng Zhu; Ming Jie Tan; Chek Kun Tan; Chee Ren Ivan Lam; Ming Keat Sng; David Tai Wei Leong; Suet Mien Tan; Sander Kersten; Jeak Ling Ding; Hoi Yeung Li; Nguan Soon Tan Journal: Blood Date: 2011-08-12 Impact factor: 22.113
Authors: E Okochi-Takada; N Hattori; T Tsukamoto; K Miyamoto; T Ando; S Ito; Y Yamamura; M Wakabayashi; Y Nobeyama; T Ushijima Journal: Oncogene Date: 2013-05-20 Impact factor: 9.867
Authors: Lionel C Clement; Carmen Avila-Casado; Camille Macé; Elizabeth Soria; Winston W Bakker; Sander Kersten; Sumant S Chugh Journal: Nat Med Date: 2010-12-12 Impact factor: 53.440
Authors: Thais de Barros Mendes Lopes; Espen E Groth; Mariana Veras; Tatiane K Furuya; Natalia de Souza Xavier Costa; Gabriel Ribeiro Júnior; Fernanda Degobbi Lopes; Francine M de Almeida; Wellington V Cardoso; Paulo Hilario Nascimento Saldiva; Roger Chammas; Thais Mauad Journal: Environ Pollut Date: 2018-06-05 Impact factor: 8.071
Authors: Jacqueline P Williams; Laura Calvi; Joe V Chakkalakal; Jacob N Finkelstein; M Kerry O'Banion; Edward Puzas Journal: Radiat Res Date: 2016-06-22 Impact factor: 2.841
Authors: Isidore Mushimiyimana; Vanesa Tomas Bosch; Nihay Laham-Karam; Minna U Kaikkonen; Henri Niskanen; Nicholas L Downes; Pierre R Moreau; Kiley Hartigan; Seppo Ylä-Herttuala Journal: Mol Cell Biol Date: 2021-06-23 Impact factor: 4.272